ViroLogic

ViroLogic, a privately held South San Francisco-based biotechnology company, is a leader in the development of novel therapy guidance tools to enable patients, physicians, and medical reimbursers to make rational treatment decisions in the management of viral diseases. The company's proprietary technology is also being used in the fields of viral pharmacogenomics to identify, analyze, and select new drug candidates for treating viral diseases and cancer, and in disease management through the development of therapy guidance algorithms to guide patient therapy. ViroLogic sales representatives have been in the field since November 1999 raising awareness among HIV-treating physicians of phenotypic testing and its benefits.

Contact Details: 270 East Grand Avenue South San Francisco CA 94080 United States of America Tel: Fax: Email: WWW: www.virologic.com/

Loading...

Recent Publications by ViroLogic:
Assessing chemokine co-receptor usage in HIV. PURPOSE OF REVIEW: HIV entry into cells is mediated through sequential...	30th April, 2005	ViroLogic Inc, South San Francisco, California 94080, USA.	Curr Opin Infect Dis. 2005 Feb;18(1):9-15.
Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. Wild-type viruses from the ViroLogic phenotype-genotype database were...	12th March, 2004	ViroLogic, Inc., South San Francisco, California 94080, USA.	Antimicrob Agents Chemother. 2004 Feb;48(2):437-43.
Polymorphisms in p1-p6/p6* of HIV type 1 can delay protease autoprocessing and increase drug susceptibility. Maturation of infectious human immunodeficiency virus type 1 (HIV-1)...	12th December, 2003	ViroLogic, South San Francisco, California 94080, USA.	AIDS Res Hum Retroviruses. 2003 Sep;19(9):779-84. DOI Direct Link
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates. Nucleoside reverse-transcriptase inhibitors (NRTIs) are important...	5th November, 2003	ViroLogic, South San Francisco, California 94080, USA.	J Infect Dis. 2003 Oct 1;188(7):992-1000. Epub 2003 Sep 16.
Practical applications of viral fitness in clinical practice. PURPOSE OF REVIEW: To review recent clinical data regarding viral fitness...	12th August, 2003	Division of Clinical Research, ViroLogic, Inc., San Francisco, CA 94080,	Curr Opin Infect Dis. 2003 Feb;16(1):11-8. DOI Direct Link
→View more ViroLogic research publications.

BioNews Results for ViroLogic:
Human Metapneumovirus Infection in Young Children Hospitalized With Acute Respiratory Tract Disease: Virologic	Medscape:  Aug 21 2008 5:20PM Matching: virologic
Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV	Rehab Manegement:  Aug 9 2008 9:02PM Matching: virologic
HIV Patients With High Viral Load Worsen on Fixed-Dose Abacavir/Lamivudine Compared With Fixed-Dose Tenofovir/	Doctors Guide:  Aug 9 2008 6:50PM Matching: virologic
Incarcerated HIV Patients Have Similar Responses to Antiretrovirals as Other Populations: Presented at AIDS 20	Doctors Guide:  Aug 9 2008 2:37AM Matching: virologic
Fosamprenavir Offers Results Similar to Those of Other Protease Inhibitors When Patients With HIV Switch Regim	Doctors Guide:  Aug 9 2008 2:37AM Matching: virologic
Promote your company here: BioNewsCast - Press Release Distribution	→View more ViroLogic news.

ViroLogic Patents:
US Patent No.	Title
7037644	Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
6942969	Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
6869759	Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
6653081	Methods for monitoring antiretroviral therapy and guiding therapeutic decision in the treatment of HIV/AIDS
6489098	Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
→View more ViroLogic patents.

ViroLogic (VLGC) Financial information Links from Barchart
VLGC Quote from from Barchart.com
VLGC Chart from from Barchart.com
VLGC Profile from from Barchart.com
VLGC Opinion from from Barchart.com
→View more ViroLogic finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 190 times since April 2007, the link to the organisation's website has been followed 45 times

Recent Search Terms used to find this page: Virologic.com | virologic.com | .

Search for more companies in South San Francisco

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ViroLogic